Andlauer Healthcare Group Inc. (TSE:AND) Director Sells C$61,309.95 in Stock

Andlauer Healthcare Group Inc. (TSE:AND - Get Free Report) Director Ronald Martin Skelton sold 1,500 shares of the business's stock in a transaction on Wednesday, May 8th. The stock was sold at an average price of C$40.87, for a total transaction of C$61,309.95.

Andlauer Healthcare Group Stock Performance

TSE:AND traded down C$0.01 during trading on Friday, reaching C$39.54. The company's stock had a trading volume of 14,896 shares, compared to its average volume of 26,585. Andlauer Healthcare Group Inc. has a 12 month low of C$36.76 and a 12 month high of C$48.80. The firm has a market cap of C$770.24 million, a price-to-earnings ratio of 25.51 and a beta of 0.69. The firm has a 50 day moving average of C$42.07 and a 200-day moving average of C$40.54. The company has a debt-to-equity ratio of 27.24, a quick ratio of 1.66 and a current ratio of 2.52.

Andlauer Healthcare Group (TSE:AND - Get Free Report) last released its earnings results on Tuesday, March 5th. The company reported C$0.44 earnings per share for the quarter, missing analysts' consensus estimates of C$0.49 by C($0.05). Andlauer Healthcare Group had a net margin of 10.21% and a return on equity of 14.53%. The company had revenue of C$169.07 million during the quarter, compared to analysts' expectations of C$165.00 million. Research analysts expect that Andlauer Healthcare Group Inc. will post 1.8439434 EPS for the current fiscal year.

Andlauer Healthcare Group Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, April 15th. Investors of record on Thursday, March 28th were paid a dividend of $0.10 per share. This is a boost from Andlauer Healthcare Group's previous quarterly dividend of $0.09. This represents a $0.40 dividend on an annualized basis and a dividend yield of 1.01%. The ex-dividend date was Wednesday, March 27th. Andlauer Healthcare Group's dividend payout ratio is presently 23.23%.

Wall Street Analysts Forecast Growth

Several brokerages recently weighed in on AND. CIBC reduced their price objective on shares of Andlauer Healthcare Group from C$52.00 to C$50.00 and set an "outperform" rating on the stock in a research note on Monday, May 6th. TD Securities decreased their price target on Andlauer Healthcare Group from C$54.00 to C$52.00 and set a "buy" rating for the company in a research note on Monday, May 6th. National Bankshares lifted their price objective on Andlauer Healthcare Group from C$46.00 to C$47.00 and gave the stock a "sector perform" rating in a research note on Thursday, March 7th. Eight Capital reduced their target price on Andlauer Healthcare Group from C$62.00 to C$58.00 and set a "buy" rating on the stock in a report on Thursday, March 7th. Finally, Royal Bank of Canada lowered their price target on shares of Andlauer Healthcare Group from C$43.00 to C$41.00 and set a "sector perform" rating for the company in a report on Monday, May 6th. Two research analysts have rated the stock with a hold rating and five have given a buy rating to the company. Based on data from MarketBeat, Andlauer Healthcare Group presently has a consensus rating of "Moderate Buy" and a consensus price target of C$49.43.

Andlauer Healthcare Group Company Profile

Andlauer Healthcare Group Inc, a supply chain management company, provides a platform of customized third-party logistics (3PL) and specialized transportation solutions for the healthcare sector in Canada and the United States. The company operates in two segments, Specialized Transportation and Healthcare Logistics.